Team,
This is very good appointment for this very capable director who has proven skills and knowledges.@hottod and@muzza, I think this shows how Jon and Team are so confident with our magic NNZ drug and now turn their attentions with full speed for other indications and the world. I think NEU is showing to the medical world and BP giants that we are taking over the world with NNZ. This will put us in superb position, basically we are working in parallel for many fronts, which means TO or not, NEU will make huge $$$$$. That is my take on this ANN.
Ann: Neuren appoints Daryl DeKarske to executive team, page-14
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.10 |
Change
0.250(1.95%) |
Mkt cap ! $1.635B | |||
| Open | High | Low | Value | Volume |
| $13.15 | $13.37 | $12.92 | $5.007M | 381.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3 | $13.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.11 | 667 | 6 |
View Market Depth
| Last trade - 13.32pm 18/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |